Fleury S.A. (FLRY3) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.063x

Based on the latest financial reports, Fleury S.A. (FLRY3) has a cash flow conversion efficiency ratio of 0.063x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$323.58 Million ≈ $63.49 Million USD) by net assets (R$5.10 Billion ≈ $999.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Fleury S.A. - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Fleury S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Fleury S.A. for a breakdown of total debt and financial obligations.

Fleury S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fleury S.A. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Chacha Food Co Ltd
SHE:002557
0.074x
Montea C.V.A.
BR:MONT
0.008x
OEM International AB (publ)
ST:OEM-B
0.095x
Kansai Nerolac Paints Limited
NSE:KANSAINER
0.031x
1st Source Corporation
NASDAQ:SRCE
0.039x
Tecan Group AG
SW:TECN
0.048x
Sylvamo Corp
NYSE:SLVM
0.090x
Veridis Environment Ltd
TA:VRDS
0.050x

Annual Cash Flow Conversion Efficiency for Fleury S.A. (2006–2025)

The table below shows the annual cash flow conversion efficiency of Fleury S.A. from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see FLRY3 stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 R$5.10 Billion
≈ $999.98 Million
R$1.57 Billion
≈ $308.32 Million
0.308x -14.16%
2024-12-31 R$5.37 Billion
≈ $1.05 Billion
R$1.93 Billion
≈ $378.80 Million
0.359x +27.54%
2023-12-31 R$5.11 Billion
≈ $1.00 Billion
R$1.44 Billion
≈ $282.42 Million
0.282x -22.94%
2022-12-31 R$2.70 Billion
≈ $530.00 Million
R$987.13 Million
≈ $193.69 Million
0.365x -33.47%
2021-12-31 R$1.85 Billion
≈ $363.88 Million
R$1.02 Billion
≈ $199.88 Million
0.549x +48.61%
2020-12-31 R$1.75 Billion
≈ $343.55 Million
R$647.14 Million
≈ $126.98 Million
0.370x -11.22%
2019-12-31 R$1.76 Billion
≈ $345.14 Million
R$732.32 Million
≈ $143.69 Million
0.416x +3.86%
2018-12-31 R$1.75 Billion
≈ $343.37 Million
R$701.49 Million
≈ $137.64 Million
0.401x +29.17%
2017-12-31 R$1.71 Billion
≈ $334.85 Million
R$529.61 Million
≈ $103.92 Million
0.310x -11.67%
2016-12-31 R$1.54 Billion
≈ $301.34 Million
R$539.57 Million
≈ $105.87 Million
0.351x +57.78%
2015-12-31 R$1.66 Billion
≈ $324.83 Million
R$368.63 Million
≈ $72.33 Million
0.223x +22.60%
2014-12-31 R$1.57 Billion
≈ $308.64 Million
R$285.71 Million
≈ $56.06 Million
0.182x +46.38%
2013-12-31 R$1.69 Billion
≈ $331.42 Million
R$209.59 Million
≈ $41.12 Million
0.124x +26.71%
2012-12-31 R$1.71 Billion
≈ $334.73 Million
R$167.05 Million
≈ $32.78 Million
0.098x +9.49%
2011-12-31 R$1.63 Billion
≈ $320.20 Million
R$145.96 Million
≈ $28.64 Million
0.089x -19.86%
2010-12-31 R$1.01 Billion
≈ $198.53 Million
R$112.92 Million
≈ $22.16 Million
0.112x +289.62%
2009-12-31 R$838.97 Million
≈ $164.62 Million
R$24.03 Million
≈ $4.72 Million
0.029x -93.99%
2008-12-31 R$151.84 Million
≈ $29.79 Million
R$72.40 Million
≈ $14.21 Million
0.477x -39.20%
2007-12-31 R$101.35 Million
≈ $19.89 Million
R$79.48 Million
≈ $15.60 Million
0.784x +16.44%
2006-12-31 R$105.91 Million
≈ $20.78 Million
R$71.33 Million
≈ $14.00 Million
0.673x --

About Fleury S.A.

SA:FLRY3 Brazil Diagnostics & Research
Market Cap
$1.72 Billion
R$8.78 Billion BRL
Market Cap Rank
#6816 Global
#71 in Brazil
Share Price
R$16.08
Change (1 day)
+0.31%
52-Week Range
R$12.46 - R$17.95
All Time High
R$26.18
About

Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and cli… Read more